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Arrhythmias are the most common cause of death associated with sudden death and are
common in US and worldwide. Cardiac resynchronization therapy (CRT), evolving from
pacemakers and development of implantable cardioverter defibrillator (ICD), has been
adopted for therapeutic use and demonstrated benefits in patients over the years due
to its design and intricate functionality. Recent research has been focused on significant
design improvement and efforts are dedicated toward device size reduction, weight and
functionality in commercially available ICD’s since its invention in the 1960’s. Commercially
available CRT-D has shown advancement on both clinical and technical side. However,
improved focus is required on the device miniaturization, technologically supported and
integrated wireless based system for real time heart monitoring electrocardiogram (ECG).
In the present report a concise overview for the state-of-the art technology in ICDs and
avenues for future development are presented. A unique perspective is also included for
ICD device miniaturization and integration of flexible sensing array. Sensor array integration
along with its capabilities for identifying localized arrhythmia detection and targeted
stimulation for enhancing ICD device capabilities is reviewed.
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BACKGROUND
Since the advent of first artificial pacemaker, much has changed
in the areas of electronics hardware, power efficiency, and pro-
gramming algorithms (Hyman, 1932; Woollons, 1995). A recent
survey forecasts that the cardiac implant market will grow by a
single digit percent each year from 2010 through 2017, and reach
estimated total revenue in excess of US $27 billion (Renub, 2013).
The emergence of integrated circuit (ICs) in 1958 and Metal
Oxide Semiconductor Field Effect Transistor (MOSFET) tech-
nology revolutionized the defibrillator product market. In recent
years, Microsemi Corp. (Santa Ana, CA) developed the new high-
voltageMOSFET for implantable cardioverter defibrillator (ICD),
which is 40 percent smaller in size and functions as an over-
voltage protection circuit in ICDs (Microsemi, 2001). American
Heart Association reports that each month about 10,000 patients
including children have ICD implanted to restore normal heart
function (Dunbar et al., 2012). ICDs are lifesaving and gener-
ally produce satisfactory results, but reduce the quality of the life
which has been primarily attributed to the technological limita-
tions of the existing designs. Therefore, efforts to improve ICDs
is essential toward producing smart next-generation devices that
result in better patient satisfaction.
In the present report, we provide a concise overview of exist-
ing ICD technologies and discuss emerging design strategies and
future improvements.
EXISTING ICD TECHNOLOGY
The ICD is a device implanted inside the high risk patients
to deliver the defibrillation pulse at the arrhythmia onset. The
size and weight of commercially available cardiac resynchro-
nization therapy-defibrillation (CRT-Ds) is shown in Figure 1A.
Subcutaneously implanted ICD systems consist of a palm-sized
metallic case and a set of leads. The metallic case includes two
parts: pulse generator (electronics hardware like microproces-
sor) and a battery. The leads consist of silicone rubber with
polyurethane outer protective coating to diagnose arrhythmia,
i.e., detection of bradycardia and/or tachycardia.
LIMITATIONS
In a report by Dunbar et al. (2012), concerns about patient’s
education and response toward ICD implants were noted. The
report identifies that ICD implanted patients do not fully under-
stand the ICD limitations related to battery, leads and electronics
hardware.
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FIGURE 1 | Implantable cardioverter defibrillator (ICD) dimensional
comparison and device integration scheme (A) size (cc) and weight
(grams) of existing CRT-D devices by major market share (CRT-D,
http://professional.sjm.com), (B) main components of proposed new
generation ICDs are shown, such as device integration, power
optimization, and Wi-Fi flexible sensor.
BATTERY
ICD devices are still large in size and shape (Sanders and
Lee, 1996), often unable to meet the patient’s demand for a
miniaturized and smart devices. A major constraint to defibrilla-
tor size reduction is the larger battery dimensions. Current ICDs
use lithium/silver-vanadium oxide batteries as a safe and clean
energy source to power the implants, as per FDA class III med-
ical device regulations (Crespi, 1993). In cathode-limited type of
ICD batteries, automatic reforming of the capacitor takes 2 weeks
of battery age to keep the low charge time (Skarstad, 2004).
LEADS
Leads convey information of cardiac rhythm to the ICD genera-
tor, and reciprocally deliver defibrillation therapy that is initiated
by the pulse generator upon detection of the arrythmogenic
events. Improper ICD lead design results in functioning defects
(Lang et al., 1995). Lead malfunctioning causes inappropriate
shocks, which may result in significant life threatening events and
even death (Maisel and Kramer, 2008).
ICDs have become more technologically advanced since its
invention in the 1960’s. Despite the advancement and its effec-
tiveness in terminating fatal arrhythmias, such as ventricular
tachycardia (VT) and ventricular fibrillation (VF), these devices
still have clinical limitations. The true incidence of device mal-
function is not certain, but adverse events associated with ICDs
can be obtained from FDA (Food and Drug Administration)
reporting (MEDWATCH program) and observational studies. In
one prospective study involving 778 patients with an ICD, com-
mon errors associated with the device were inappropriate shock
therapy (16%) and ICD/lead dislodgement (4%) (Rosenqvist
et al., 1998). Lead failure can also pose a problem result-
ing in the necessity for revision in 2.5% (95% CI 1.5–3.6)
patients at the 5 years mark in one study involving 1317 patients
(Eckstein et al., 2008). Lead malfunction can be due to a vari-
ety of causes such as wire fractures and insulation problems
in the pace/sensing lead resulting in an inappropriate sens-
ing or firing. When this occurs the pace/sensing lead must be
replaced. However, if the malfunction is due to the high-voltage
part of the lead, the entire defibrillator lead must be replaced.
Investigators from this same study found that lead failure could
be rectified by adding an additional pace/sense lead in 63% of the
cases.
Previous reports also note that at times the ICD can pro-
duce a shock inadvertently for conditions other than VT or VF,
often referred as inappropriate therapy. They may be burdensome
to patients who receive painful shocks (Healey and Connolly,
2008; Mark et al., 2008). In the MADIT (Multicenter Automatic
Defibrillator Implantation Trial) II inappropriate shocks due
to wrong rhythm selection occurred in 11.5% of the patients
with ICD’s (Daubert et al., 2008). In these patients the trigger
for inadvertent shocks mainly included atrial flutter/fibrillation,
supraventricular tachycardia or abnormal sensing. The use of dual
chamber devices can decrease the odds of inappropriate shocks vs.
single chamber devices by sensing supraventricular arrhythmias
(OR 0.53 95% CI 0.3–0.94; P = 0.03) (Friedman et al., 2006).
Electrical noise, diaphragmatic potentials, and sensing of non-
sustained VT are other examples when inappropriate therapymay
occur (Germano et al., 2006).
Despite the proven benefits when an ICD is functioning prop-
erly, there is also evidence suggesting ICDs can cause structural
damage, myocardial damage or even be arrythmogenic. In one
small retrospective chart review, 41 patients who had severe tri-
cuspid regurgitation due to ICD or permanent pacemakers (PPM)
were evaluated (Lin et al., 2005). This study found that PPM and
ICDs accounted for 17% of tricuspid valve leaflet perforations.
Lead adherence to tricuspid valve and lead entanglement in the
tricuspid valve occurred in 34 and 9% of patients, respectively.
Evidence suggesting that ICDs have the potential to be proarry-
thmic is anecdotal. Hypothesis behind this theory is that the leads
may cause local irritation of the myocardium. Additionally, due to
poor sensing by ICD, inappropriate pacing can lead to ventricu-
lar arrhythmias. It is also well known that right ventricular pacing
can exacerbate heart failure. In patients with that condition, this
can increase the risk of ventricular arrhythmias (Germano et al.,
2006). Twiddler’s syndrome was first noted 45 years ago in some
patients that developed a tendency to twist and turn the device
(subconsciously or intentionally) in the surgical pocket, which can
cause the leads to dislodge resulting in device failure. With smaller
devices that can better fit the pocket space, this condition can be
mitigated (Nicholson et al., 2003). Additional challenges include
battery depletion, and electromagnetic interference from nearby
wireless communication systems (Glikson and Friedman, 2001).
Tissue growth on leads induces threats on signal sensing and
leads displacement. Novel biomaterial coated sensing electrodes
are a potential solution to prevent tissue growth and improved
interfacing (Monteiro et al., 2009).
NEXT GENERATION INTEGRATED ICD
In order to improve the current ICD functionalities and size lim-
itation, there is a need to follow a system of systems approach
where hardware and software, such as analog (arrhythmia detec-
tion sensors) and digital system components, (microcontroller,
RAM data storage) must be integrated as per overall system
requirements. The ICD’s central processing unit is a micropro-
cessor which controls the output of the ICD unit depending on
the information received from the system sensors.
DEVICE MINIATURIZATION
The main focus of ICD miniaturization is on comfortable fit
device design and battery size reduction (Figure 1B). Important
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parameters in device miniaturization include battery volume,
energy density and specific energy. Especially the latter two
parameters are responsible for longer battery life in ICDs. To
reduce the volume, the battery shape should conform to the inter-
nal ICD device geometry. Hybrid battery technology is progress-
ing toward the use of lithium polymer materials, rechargeable
and high-density thin-film batteries. Due to the advancements in
nanotechnology, new generation microbatteries that occupy sur-
prisingly less space are capable of delivering power and energy
for longer periods of time (Xu et al., 2013). Charging through
inductive coupling prolongs longevity, reduces space, and ulti-
mately reduces the cost of surgery and chances of infection.
Piezoelectric materials and ultrasonic energy could be used even
under magnetic resonance imaging (MRI) environment (Karami
and Inman, 2012).
FLEXIBLE SENSOR ARRAY
Current ICD devices detect heart rhythm and sense arrhythmias
using lead based system. The microprocessor’s decision mak-
ing capabilities depend on this arrhythmia information acquired
from atrial and ventricular chambers. The major limitation of
this approach is the lack of spatial resolution of information.
For complete signal analysis and accurate decision making, the
microprocessor requires information at the site of arrhythmia
generation. This approach enhances the microprocessor’s deci-
sion making skills and ICD’s sensing capabilities as an integrated
system.
The present state-of-the-art sensors are based on silicon com-
plementary metal oxide semiconductor (CMOS) technology,
which is rigid, non-conformal, and loses interface connections
with tissue movement. Conformable and flexible sensors are able
to interface soft, stretchable, and wet biological tissue. The flex-
ible sensor technology, which is currently under research and
development phase and being tested in animal models, would
offer a promising solution in this area (Kim et al., 2012a). The
flexible wireless sensors incorporated into the ICD device would
be a step forward toward new generation ICDs (Sanders et al.,
2005). The cardiac surface is curvilinear and soft, hindering the
development of devices for bio-integration. The integrated array
consists of flexible transistorized (FETs) sensors for measuring
electrophysiological signals from the outer surface of the heart
(Kim et al., 2012b). The programmed algorithm in the ICD
detects and decides whether pacing or defibrillation is needed
and accordingly the control signal is delivered. The sensor array
can be advantageous for large surface area sensing, spatial res-
olution, and arrythmia localization. The impulses can be deliv-
ered by ICD leads or sensor array depending upon the origin
of the arrhythmia. The cardiac sensing array can be designed
with a separate power source to meet the minimum comput-
ing requirements of flexible sensors. The engineering design of
the flexible sensor array may allow for an intact and conformal
tissue-electronics interface. Battery power optimization needs to
be studied to create flexible Wi-Fi cardiac sensor with optimal
onsite memory (flexible RAM) options. Luther et al. demon-
strated that applying a series of five small shocks, instead of
single large one, reduces the energy amount needed by approx-
imately 84% and reset the heart arrhythmias (Luther et al.,
2011).
Electrocardiograms (ECG) detect heart abnormlities only at
the time of the diagnostic test. Advanced micro processing chips
are available for onsite sensing and decision making to detect
various body movements, blood pressure, and pulmonary fluid.
Figure 2 shows the complete ICD device miniaturization and
wireless flexible sensor integration scheme. Wi-Fi based inte-
grated sensors collect real-time data and transmit noise free
original electrical signals from the cardiac surface. Multi-sensor
array provides opportunities for understanding pulse pattern,
local tissue behavior on defibrillation, diagnosing arrhythmias,
and controlled tissue stimulation. Noise cancelling algorithms
and circuits that can discriminate electromegnetic interference
(EMI) must be designed to prevent the ICDs from triggering
undesirable impulses. Supplying power through remote source
using ultrasound is a novel concept under investigation for its
application to ICD (Cheung and Neyzari, 1984). Piezoelectric
materials based biasing systems can also be an alternative energy
source (Ward et al., 2009).
WIRELESS SENSING DATA TRANSFER
Current sensing and data transfer rely on leads, which is a
major variable of concern in successfully ICD function. In order
to circumvent these lead related limitations, wireless sensing
array integration to ICD is a novel step toward collecting high
resolution and quality signal information. Onsite computing
(i.e., signal amplification) and ECG analysis are useful appli-
cations toward sensor design engineering which can be used
for various biomedical applications. Real-time ECG monitoring
and wireless programmability provide immediate information to
healthcare providers to extend beyond the capabilities of con-
ventional ICDs. Further development of advanced algorithms
to detect and differentiate between fatal and non-fatal arrhyth-
mia and to deliver proportionate shock will be an additional
FIGURE 2 | Work flow chart of ICD functioning and flexible sensor array
system (A) flow chart illustratesworking principle of ICD and alert signal
activation, microprocessor trigger pacing or defibrillation impulse on
arrhythmias onset (B) major internal building blocks of ICD device, like
battery, microprocessor, and RAM memory. Flexible sensor array which
consisting of transistors (FETs) fabricated on polyimide flexible substrate.
(C) Block diagram of telemetry/programming unit to record clinically relevent
data and connected with cardiologist/clinic for any emergency.
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dimension toward inventing the new generation of smart ICDs.
Telemetric synchronization of ICDs for the transmission of clini-
cally useful data to doctors can be useful to handle any emergency
situation.
In the present review an overview of device miniaturiza-
tion, better sensing, impulse delivery, data transfer methods, and
device integration information is provided for designing new
generation smart device.
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